$250 million. That’s what the industry spent advertising Camp Lejeune from 2022 to 2024. The biggest mass tort ad blitz in history. And most of it was wasted.
The filing deadline closed August 10, 2024. The lead market is dead. No new claims. No new cases.
What’s left is 3,715 federal lawsuits, 410,000 administrative claims, and a $21 billion government fund that hasn’t paid out more than a fraction.
This tort isn’t a case study in opportunity. It’s a case study in what happens when the industry loses discipline.
The Numbers
The PACT Act created the Camp Lejeune Justice Act in August 2022, opening a two-year window for anyone exposed to contaminated water at Marine Corps Base Camp Lejeune between 1953 and 1987.
Four hundred ten thousand claims. But here’s the number nobody advertises.
Only 13,687 met the documentation threshold for settlement consideration. That’s 3.3% of total filings.
The gap between claims filed and claims qualified is the single most important data point in mass tort advertising. It tells you exactly how much money was burned on unqualified intake.
The Money That Was Spent
Bloomberg Law tracked $111 million in TV spending alone during 2022. September 2022 hit $22 million in a single month. More than double the next closest tort.
Add digital, social, radio, and programmatic. Total: roughly $250 million in combined advertising.
Most of it came from lead generation companies, not law firms. The pattern was predictable. Lead gen buys media at scale, generates volume, sells signed retainers to firms at $3,500-$5,000 per case. Markup is the business model. Quality isn’t.
The result was catastrophic for intake quality. Indian call centers fabricating medical records. Claimants denied by one firm calling the next, refining their story until they sounded qualified. Multiple agencies collapsed under fraud exposure.
One industry observer described it as the campaign that “nearly obliterated the mass tort marketing space.”
The Lead Economics (Post-Mortem)
The lead market followed a textbook lifecycle. And then it crashed.
At peak (early 2023), signed retainers cost $4,000-$5,000. Raw leads ran $2,000-$2,500. By mid-2024, retainer costs dropped to $1,300-$3,000 as the filing deadline approached and inventory quality deteriorated.
After August 2024? Zero. The deadline closed. No new claims accepted.
Here’s the math that matters. The industry spent $250 million in advertising to generate 410,000 claims. Only 14,000 met documentation thresholds. That’s $17,800 per documentable claim in advertising alone.
Before anyone touched a case file.
The Settlement Landscape
The government allocated $21-22 billion to resolve Camp Lejeune claims. That sounds enormous. It isn’t moving fast.
The Elective Option (EO) program offers expedited payouts. The DOJ created a tiered structure.
Tier 1 covers the highest-severity conditions: bladder cancer, kidney cancer, liver cancer, leukemia, non-Hodgkin’s lymphoma. Tier 2 covers Parkinson’s, other cancers, and qualifying conditions.
Payouts range from $100,000 to $550,000 based on disease and exposure duration.
The problem isn’t acceptance rate. It’s volume. Over 2,300 offers approved out of 410,000 claims. Most plaintiffs’ attorneys consider the EO amounts lowball compared to projected litigation values of $175,000 to $1.5 million.
And the government is fighting every dollar. The DOJ argues all VA, Medicare, and Medicaid benefits should be subtracted dollar-for-dollar from any award. Including projected future benefits.
No Trials Yet
Zero bellwether verdicts. In a tort with 3,715 federal lawsuits and a $21 billion allocation.
Two Settlement Masters were appointed in 2025 to develop a global settlement framework. Three status reports filed. The goal of a framework by end of 2025 was optimistic. Realistic timeline: 2027, with meaningful payouts stretching into 2028 and beyond.
The DOJ is playing defense. Over 30 motions targeting expert testimony. Motions for summary judgment. Attempts to block medical record updates. An argument to exclude ATSDR water models as proof of individual exposure.
The government isn’t acting like a compensatory program. It’s litigating like a defendant.
Track 1 bellwether cases cover bladder cancer, kidney cancer, NHL, leukemia, and Parkinson’s. Twenty-five mediations produced three resolutions. Those odds aren’t encouraging for fast resolution.
Who Was Exposed
The ATSDR tracked the contamination to trichloroethylene, perchloroethylene, benzene, and vinyl chloride in the water supply at Hadnot Point and Tarawa Terrace treatment facilities.
An estimated one million Americans were exposed. Marines, families, civilian employees, contractors. Anyone who lived or worked on base for at least 30 days between August 1953 and December 1987.
In utero exposure qualifies. Wrongful death claims are eligible regardless of how long ago the person died.
The Channel Mix (Historical)
During peak advertising, broadcast dominated at roughly 50%. The creative was simple. “Were you stationed at Camp Lejeune?” Running on daytime TV, cable news, and local broadcast.
Social captured about 20%. Heavy Meta targeting. High volume, terrible quality.
Search ran about 12%. “Camp Lejeune lawsuit” keywords were brutal on CPC, but conversion was stronger because searchers already knew they had exposure.
CTV barely registered at 3%. The industry hadn’t adopted streaming for mass tort at scale during the 2022-2023 blitz. That’s the channel gap that would’ve mattered.
The Lesson
Camp Lejeune is a cautionary tale.
The advertising worked in the sense that it generated volume. Four hundred ten thousand claims. But only 3.3% qualified. The fraud was industrial. The waste was staggering.
Firms that ran their own intake with rigorous qualification emerged with portfolios worth real money. Firms that bought leads from third-party vendors at $5,000 per retainer are still waiting to find out how many of those cases actually have documentation.
The Play (For Firms Holding Cases)
If you’re sitting on Camp Lejeune inventory, three things matter now.
First, document everything. The government is fighting on offsets, expert exclusions, and individual exposure proof. Cases without solid medical records, service records, and exposure documentation won’t survive.
Second, watch the bellwether schedule. The first verdicts will set the market for global settlement negotiations. If plaintiffs win big, the EO framework gets torn up. If the government wins, the EO becomes the best deal available.
Third, stop waiting for fast resolution. The Settlement Masters are working. The DOJ is stalling. Realistic payouts: 2028 or later for most claimants.
The firms that win Camp Lejeune cases won’t be the ones that spent the most on advertising. They’ll be the ones who qualified hardest from day one and documented every case as if it were going to trial.
Most didn’t.
References
- Camp Lejeune Justice Act, Section 804 of the PACT Act, Public Law 117-168 (August 10, 2022)
- Agency for Toxic Substances and Disease Registry (ATSDR). Camp Lejeune Water Contamination
- Bloomberg Law. Camp Lejeune Ad Blitz Tops $111 Million in TV Spending, 2023
- Reuters. Camp Lejeune litigation update: Settlement framework and trial schedule, 2025
- U.S. Department of the Navy. Camp Lejeune Justice Act Elective Option Settlement Program